Education
About Us
Working with TipRanks
Follow Us
Wave Life Sciences (WVE)
NASDAQ:WVE
Wve-N531
Duchenne Muscular Dystrophy
Phase II
Not Yet Recruiting
Open-Label Extension Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy
Aug 14, 2025
―
Wve-007
Obesity And Overweight
Phase I
Recruiting
A Phase 1 Study of WVE-007 in Adults Living with Overweight or Obesity
Jan 29, 2025
―
Wve-006
Alpha-1 Antitrypsin Deficiency
Phase I/II
Recruiting
A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ AATD
May 03, 2024
―
Wve-006
Alpha-1 Antitrypsin Deficiency
Phase I
Completed
A Phase 1 Research Study to Evaluate Safety, Tolerability, and Pharmacokinetics of WVE-006 in Healthy Participants With Wild-type AAT Expression (RestorAATion-1)
Nov 09, 2023
―
Sad: 30Mg Wve-003, Sad: 60Mg Wve-003, Sad: 90Mg Wve-003, Md: 30Mg Wve-003
Huntington Disease
Phase I/II
Completed
Study of WVE-003 in Patients With Huntington's Disease
Aug 18, 2021
―
Wve-N531
Duchenne Muscular Dystrophy
Phase I/II
Recruiting
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
May 24, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Wave Life Sciences (WVE) have in its pipeline
WVE is currently developing the following drugs: Wve-N531, Wve-007, Wve-006. These drug candidates are in various stages of clinical development as the company works toward FDA approval.